Acute and chronic neurological disorders in COVID-19: potential mechanisms of disease
Abstract Coronavirus disease 2019 (COVID-19) is a global pandemic caused by SARS-CoV-
2 infection and is associated with both acute and chronic disorders affecting the nervous …
2 infection and is associated with both acute and chronic disorders affecting the nervous …
Cerebrospinal fluid in COVID-19: a systematic review of the literature
A Lewis, J Frontera, DG Placantonakis, J Lighter… - Journal of the …, 2021 - Elsevier
Objective We sought to review the literature on cerebrospinal fluid (CSF) testing in patients
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …
with COVID-19 for evidence of viral neuroinvasion by SARS-CoV-2. Methods We performed …
[HTML][HTML] High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms
C Franke, C Ferse, J Kreye, SM Reincke… - Brain, behavior, and …, 2021 - Elsevier
Background COVID-19 intensive care patients can present with neurological syndromes,
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of …
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of …
SARS-CoV-2 spike S1 subunit induces neuroinflammatory, microglial and behavioral sickness responses: Evidence of PAMP-like properties
MG Frank, KH Nguyen, JB Ball, S Hopkins… - Brain, behavior, and …, 2022 - Elsevier
SARS-CoV-2 infection produces neuroinflammation as well as neurological, cognitive (ie,
brain fog), and neuropsychiatric symptoms (eg, depression, anxiety), which can persist for …
brain fog), and neuropsychiatric symptoms (eg, depression, anxiety), which can persist for …
[HTML][HTML] Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up
Background Neurologic manifestations are well-recognized features of coronavirus disease
2019 (COVID-19). However, the longitudinal association of biomarkers reflecting CNS …
2019 (COVID-19). However, the longitudinal association of biomarkers reflecting CNS …
[HTML][HTML] SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
FL Fontes-Dantas, GG Fernandes, EG Gutman… - Cell reports, 2023 - cell.com
Cognitive dysfunction is often reported in patients with post-coronavirus disease 2019
(COVID-19) syndrome, but its underlying mechanisms are not completely understood …
(COVID-19) syndrome, but its underlying mechanisms are not completely understood …
[HTML][HTML] COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance
A Achar, C Ghosh - Cells, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …
[HTML][HTML] CSF biomarkers in COVID-19 associated encephalopathy and encephalitis predict long-term outcome
M Guasp, G Muñoz-Sánchez… - Frontiers in …, 2022 - frontiersin.org
Patients with coronavirus disease 2019 (COVID-19) frequently develop acute
encephalopathy and encephalitis, but whether these complications are the result from viral …
encephalopathy and encephalitis, but whether these complications are the result from viral …
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive …
JA Frontera, A Boutajangout, AV Masurkar… - Alzheimer's & …, 2022 - Wiley Online Library
Introduction Neurological complications among hospitalized COVID‐19 patients may be
associated with elevated neurodegenerative biomarkers. Methods Among hospitalized …
associated with elevated neurodegenerative biomarkers. Methods Among hospitalized …